Published in J Clin Oncol on July 01, 2001
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg (2004) 3.72
Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology (2012) 1.76
Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg (2007) 1.75
High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg (2003) 1.63
Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer (2010) 1.56
The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg (2004) 1.55
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clin Cancer Res (2009) 1.47
Simultaneous adrenal and extra-adrenal myelolipoma - an uncommon incident: case report and review of the literature. World J Surg Oncol (2008) 1.46
Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas. Pediatr Blood Cancer (2012) 1.15
Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys (2009) 1.08
Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas. J Nucl Med (2008) 1.05
Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma. Ann Surg Oncol (2010) 1.03
Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions. AJR Am J Roentgenol (2012) 0.92
Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity. Ann Surg Oncol (2014) 0.90
PEComa of the Upper Extremity: A Unique Case and Description of an Initial Response to Neoadjuvant Chemotherapy. Sarcoma (2007) 0.89
Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. Anticancer Res (2012) 0.86
Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial. BMC Cancer (2014) 0.85
Posttherapy residual disease associates with long-term survival after chemoradiation for bulky stage 1B cervical carcinoma: a Gynecologic Oncology Group study. Am J Obstet Gynecol (2010) 0.84
18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy. Clin Cancer Res (2012) 0.82
Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cells. PLoS One (2014) 0.82
Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy. Cancer (2014) 0.81
Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study. J Orthop Sci (2008) 0.81
Radiation therapy for palliation of sarcoma metastases: a unique and uniform hypofractionation experience. Sarcoma (2010) 0.81
Neoadjuvant and adjuvant chemotherapy with modified mesna, adriamycin, ifosfamide, and dacarbazine (MAID) regimen for adult high-grade non-small round cell soft tissue sarcomas. Int J Clin Oncol (2011) 0.79
The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane. Sarcoma (2006) 0.78
[Radiotherapy of soft tissue sarcoma--part of a multidisciplinary strategy]. Wien Klin Wochenschr (2008) 0.78
Hypofractionated adjuvant radiation therapy of soft-tissue sarcoma achieves excellent results in elderly patients. Br J Radiol (2013) 0.78
Semi-automated volumetric quantification of tumor necrosis in soft tissue sarcoma using contrast-enhanced MRI. Anticancer Res (2012) 0.77
The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas. World J Surg Oncol (2013) 0.77
Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging Sequences. Radiology (2015) 0.77
Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy. Radiat Oncol (2013) 0.77
Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma. Cancer (2015) 0.76
Neoadjuvant radiation in primary extremity liposarcoma: correlation of MRI features with histopathology. Eur Radiol (2015) 0.76
Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma. Br J Cancer (2014) 0.75
Multimodality treatment of locally advanced soft-tissue sarcomas of the extremities. Rep Pract Oncol Radiother (2010) 0.75
Radiographic response to neoadjuvant therapy and its impact on scope of surgery and prognosis in stage IIB/III soft tissue sarcomas. BMC Cancer (2013) 0.75
Evaluation of Soft Tissue Sarcoma Response to Preoperative Chemoradiotherapy Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Tomography (2016) 0.75
Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients. Medicine (Baltimore) (2016) 0.75
An unresectable retroperitoneal malignant fibrous histiocytoma: A case report. Oncol Lett (2016) 0.75
Texture Analysis of Non-Contrast-Enhanced Computed Tomography for Assessing Angiogenesis and Survival of Soft Tissue Sarcoma. J Comput Assist Tomogr (2015) 0.75
Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS). Cancer Chemother Pharmacol (2015) 0.75
Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively. Am J Clin Oncol (2016) 0.75
A non-comparative phase II study of dose intensive chemotherapy with doxorubicin and ifosfamide followed by high dose ICE consolidation with PBSCT in non-resectable, high grade, adult type soft tissue sarcomas. Invest New Drugs (2013) 0.75
Neoadjuvant Hypofractionated Radiotherapy and Chemotherapy in High-Grade Extremity Soft Tissue Sarcomas: Phase 2 Clinical Trial Protocol. JMIR Res Protoc (2017) 0.75
FDG PET imaging guided re-evaluation of histopathologic response in a patient with high-grade sarcoma. Skeletal Radiol (2003) 0.75
Preoperative chemotherapy for soft tissue sarcomas: reinventing the wheel. Skeletal Radiol (2008) 0.75
Clinical identification of colorectal cancer patients benefiting from adjuvant uracil-tegafur (UFT): a randomized controlled trial. J Cancer Res Clin Oncol (2008) 0.75
Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications. Ther Adv Med Oncol (2017) 0.75
Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol (2001) 4.22
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol (1992) 3.86
Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer (1982) 3.82
Impaired immunologic reactivity and recurrence following cancer surgery. Cancer (1970) 3.77
N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci U S A (1984) 3.09
Leiomyosarcoma of the inferior vena cava: prognosis and comparison with leiomyosarcoma of other anatomic sites. Cancer (1999) 2.81
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene (2000) 2.61
Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery (1970) 2.34
Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med (1976) 2.33
Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J Urol (1996) 2.25
National organ matching and distribution service. Br Med J (1974) 2.22
Public health: then and now. The first neighborhood health center movement--its rise and fall. Am J Public Health (1971) 2.19
BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg (1974) 2.14
Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol (1997) 2.14
Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer (1979) 2.11
Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluorocarbons. Lancet (1997) 2.09
Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med (1977) 2.06
The natural history of Peyronie's disease. J Urol (1990) 2.02
Depression and somatization: a review. Part I. Am J Med (1982) 2.00
Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer (1976) 1.97
Differences between patients' and physicians' evaluations of outcome after total hip arthroplasty. J Bone Joint Surg Am (1996) 1.89
Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. Cancer (1994) 1.84
Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3'-hydroxyacetanilide, in mouse liver. J Biol Chem (1989) 1.75
Interferon activation of "pre-spontaneous killer" (pre-SK) cells and alteration in kinetics of lysis of both "pre-SK" and active SK cells. J Immunol (1980) 1.75
Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis. Mol Pharmacol (1976) 1.73
Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann Surg (1970) 1.68
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res (2001) 1.61
Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol (1987) 1.59
Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. N Engl J Med (1976) 1.57
Etiology and results of tumor endoprosthesis revision surgery in 64 patients. Clin Orthop Relat Res (1999) 1.56
Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med (1996) 1.55
The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol (1985) 1.54
Diagnosis of glenoid labral tears. A comparison between magnetic resonance imaging and clinical examinations. Am J Sports Med (1996) 1.52
Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature. Cancer (1996) 1.51
Intraoperative frozen section monitoring of nerve sparing radical retropubic prostatectomy. J Urol (1999) 1.49
Mesenchymal chondrosarcoma. A clinicopathologic analysis of 35 patients with emphasis on treatment. Cancer (1983) 1.49
Specificity and sensitivity of the assay for elastin-derived peptides in chronic obstructive pulmonary disease. Am Rev Respir Dis (1992) 1.48
Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience. Cancer (1992) 1.47
Is amputation necessary for sarcomas? A seven-year experience with limb salvage. Ann Surg (1980) 1.46
Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiological-pathological correlation in 63 patients. Radiology (1982) 1.46
Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas. Ann Surg Oncol (1999) 1.46
Making do without randomised trials. J Bone Joint Surg Br (1994) 1.46
Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck (1992) 1.46
Prosthetic replacement of the inferior vena cava for malignancy. J Vasc Surg (1998) 1.45
Arthroplasty of the first metatarsophalangeal joint with a double-stem silicone implant. Results in patients who have degenerative joint disease failure of previous operations, or rheumatoid arthritis. J Bone Joint Surg Am (1992) 1.45
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol (2000) 1.44
High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer (1974) 1.44
The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys (1997) 1.42
Hemifacial spasm associated with external carotid artery compression of the facial nerve. J Laryngol Otol (1996) 1.40
Retroperitoneal sarcomas: a reappraisal of treatment. J Surg Oncol (1981) 1.40
A slaughter of innocents: aspects of child health in the 18th-century city. Stud Eighteenth Cent Cult (1976) 1.39
Health is a community affair. A bookshelf compiled from the reports of the National Task Forces project. Am J Public Health Nations Health (1967) 1.39
A bookshelf on poverty and health. Am J Public Health Nations Health (1969) 1.39
Survivorship analysis in the evaluation of joint replacement. J Arthroplasty (1986) 1.38
Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol (1993) 1.38
The indications for polysomnography and related procedures. Sleep (1997) 1.38
Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat. Science (1976) 1.38
Primary immunolocalization of estrogen and progesterone target cells in the human anterior cruciate ligament. J Orthop Res (1996) 1.37
Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy. J Clin Oncol (1999) 1.36
Notching of the femoral neck during resurfacing arthroplasty of the hip: a vascular study. J Bone Joint Surg Br (2006) 1.36
Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol (1991) 1.35
Deep sepsis following total knee arthroplasty. Ten-year experience at the University of California at Los Angeles Medical Center. J Bone Joint Surg Am (1986) 1.35
Neurofibrosarcoma. Cancer (1980) 1.33
Specialization in public health. Am J Public Health (1972) 1.33
Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion. J Clin Oncol (1993) 1.32
Proceedings: Disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy. Cancer (1974) 1.31
The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol (1994) 1.29
The American Journal of Public Health: antecedents, origin and evolution. Am J Public Health (1972) 1.28
Advances in the treatment of sarcomas of the extremity. Current status of limb salvage. Cancer (1984) 1.28
Immunologic studies of human sarcomas: Additional evidence suggesting an associated sarcoma virus. Cancer (1970) 1.27
The fibroma-like variant of epithelioid sarcoma. A fibrohistiocytic/myoid cell lesion often confused with benign and malignant spindle cell tumors. Cancer (1992) 1.27
The UCLA experience in limb salvage surgery for malignant tumors. Orthopedics (1985) 1.27
Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy. J Cancer Res Clin Oncol (1983) 1.27
Primary musculoskeletal neoplasms: effectiveness of core-needle biopsy. Radiology (1999) 1.27
Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: a ten year experience. Orthopedics (1985) 1.26
Thyroglossal cysts and tracts. A histological and histochemical study. Ann Otol Rhinol Laryngol (1968) 1.25
Ewing's sarcoma: ten-year experience with adjuvant chemotherapy. Cancer (1981) 1.24
Depression and somatization: a review. Part II. Am J Med (1982) 1.24
Total femoral endoprosthetic reconstruction. Clin Orthop Relat Res (1995) 1.23
Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging. AJR Am J Roentgenol (1991) 1.23
Advantages of low dose steroid from the day after renal transplantation. Transplantation (1980) 1.22
THARIES resurfacing arthroplasty. Evolution and long-term results. Clin Orthop Relat Res (1986) 1.22
Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med (1990) 1.22
Immunochemical studies of intestinal disaccharidases during normal and precocious development. Proc Natl Acad Sci U S A (1965) 1.21
Deconvolving an Estimate of Breath Measured Blood Alcohol Concentration from Biosensor Collected Transdermal Ethanol Data. Appl Math Comput (2008) 1.20
Acetaminophen-induced oxidation of protein thiols. Contribution of impaired thiol-metabolizing enzymes and the breakdown of adenine nucleotides. J Biol Chem (1990) 1.19
Synovial sarcoma. A study of intensive chemotherapy in 14 patients with localized disease. Cancer (1993) 1.19
Correlation between chlamydia infection and clinical evaluation, vaginal wet smear, and cervical swab test in female adolescents. Am J Obstet Gynecol (1987) 1.18
Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol (1994) 1.18
Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients. Cancer J Sci Am (1997) 1.18
Molecular basis for several drug-induced nephropathies. Am J Med (1977) 1.18